EP3458053

USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    19.5.2017
  • :
    8.12.2021
  • :
    17800310.9
  • :
    18.5.2037
  • :
    USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS

19.5.2017
8.12.2021
  • :
    Biohaven Pharmaceutical Holding Company Ltd.
  • :
    234 Church Street Suite 301, New Haven, CT 06520, US
  • :
    CORIC, Vladimir
  • :
    New Haven Connecticut 06520, US
  • :
    201662339433 P
  • :
    20.5.2016
  • :
    US
  • :
    US2017033688
  • :
    19.5.2017
  • :
    A61K 31/428, C07D 277/82, A61P 35/00